Zhi Pang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Editorial: Biomedical sensing in assistive devices.
Journal: Frontiers in bioengineering and biotechnology
Published: January 29, 2026
Editor's Note: Lung Tumor Suppressor GPCR5A Binds EGFR and Restrains Its Effector Signaling.
Journal: Cancer research
Published: October 31, 2025
Gait phase recognition of children with cerebral palsy via deep learning based on IMU data from a soft ankle exoskeleton.
Journal: Frontiers in bioengineering and biotechnology
Published: August 08, 2025
Development and validation of a novel criterion of histologic healing in ulcerative colitis defined by inflammatory cell enumeration in lamina propria mucosa: A multicenter retrospective cohort in China.
Journal: Chinese medical journal
Published: December 12, 2023
Development and validation of a novel therapeutic drug monitoring-based nomogram for prediction of primary endoscopic response to anti-TNF therapy in active Crohn's disease.
Journal: Therapeutic advances in gastroenterology
Published: October 09, 2023
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges.
Journal: Biomarker research
Published: July 26, 2023
Ulcerative colitis alleviation of colon-specific delivered rhamnolipid/fullerene nanocomposites via dual modulation in oxidative stress and intestinal microbiome.
Journal: Journal of materials chemistry. B
Published: June 13, 2023
Novel Homozygous PADI6 Variants in Infertile Females with Early Embryonic Arrest.
Journal: Frontiers in cell and developmental biology
Published: November 22, 2021
MUC1 triggers lineage plasticity of Her2 positive mammary tumors.
Journal: Oncogene
Published: November 16, 2021
Hsa_circRNA_103124 Upregulation in Crohn's Disease Promotes Cell Proliferation and Inhibits Autophagy by Regulating the Hsa-miR-650/AKT2 Signaling Pathway.
Journal: Frontiers in genetics
Published: August 04, 2021
The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma.
Journal: Frontiers in medicine
Published: July 12, 2021
Last Updated: 09/26/2026